Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Atherosclerosis: cell biology and lipoproteins.
Lu H, Daugherty A.
Curr Opin Lipidol. 2011 Aug;22(4):322-3. No abstract available.
Related citations
Hyperlipidemia and cardiovascular disease: triglycerides - a revival of cardiovascular risk factor?
Nofer JR.
Curr Opin Lipidol. 2011 Aug;22(4):319-21. No abstract available.
Current world literature.
[No authors listed]
Curr Opin Lipidol. 2011 Aug;22(4):308-10. No abstract available.
Neural regulation of cholesterol metabolism.
Perez-Tilve D, Habbeger KM, Tschöp MH, Hofmann SM.
Curr Opin Lipidol. 2011 Aug;22(4):283-7. Review.
Lipoprotein glomerulopathy.
Tsimihodimos V, Elisaf M.
Curr Opin Lipidol. 2011 Aug;22(4):262-9. Review.
Unexpected roles for PCSK9 in lipid metabolism.
Soutar AK.
Curr Opin Lipidol. 2011 Jun;22(3):192-6. Review.
Hepatic fatty acid partitioning.
Hodson L, Frayn KN.
Curr Opin Lipidol. 2011 Jun;22(3):216-24. Review.
Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
Saha SA, Arora RR.
Curr Opin Lipidol. 2011 Aug;22(4):270-6. Review.
Genetic bases of hypertriglyceridemic phenotypes.
Johansen CT, Hegele RA.
Curr Opin Lipidol. 2011 Aug;22(4):247-53. Review.
Gene-gene and gene-environment interactions defining lipid-related traits.
Ordovás JM, Robertson R, Cléirigh EN.
Curr Opin Lipidol. 2011 Apr;22(2):129-36. Review.
Combining genome-wide data from humans and animal models of dyslipidemia and atherosclerosis.
Berisha SZ, Smith JD.
Curr Opin Lipidol. 2011 Apr;22(2):100-5. Review.
Sortilins: new players in lipoprotein metabolism.
Willnow TE, Kjølby M, Nykjaer A.
Curr Opin Lipidol. 2011 Apr;22(2):79-85. Review.
Evidence for use of fibrates in diabetic dyslipidemia: are we looking hard enough?
Munigoti SP, Rees A.
Curr Opin Lipidol. 2011 Feb;22(1):76-7. Review. No abstract available.
Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective.
Elam M, Lovato LC, Ginsberg H.
Curr Opin Lipidol. 2011 Feb;22(1):55-61. Review.
Bariatric surgery: results in obesity and effects on metabolic parameters.
Clifton PM.
Curr Opin Lipidol. 2011 Feb;22(1):1-5. Review.
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe.
Thompson GR, Catapano A, Saheb S, Atassi-Dumont M, Barbir M, Eriksson M, Paulweber B, Sijbrands E, Stalenhoef AF, Parhofer KG.
Curr Opin Lipidol. 2010 Dec;21(6):492-8. Review.
Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Brouwers MC, de Graaf J, van Greevenbroek MM, Schaper N, Stehouwer CD, Stalenhoef AF.
Curr Opin Lipidol. 2010 Dec;21(6):530-8. Review.
Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart disease.
Curr Opin Lipidol. 2010 Aug;21(4):392-3. No abstract available.
Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
Datta BN, McDowell IF, Rees A.
Curr Opin Lipidol. 2010 Aug;21(4):366-71. Review.
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
Virani SS, Ballantyne CM.
Curr Opin Lipidol. 2010 Apr;21(2):165-6. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on